Key Decisions in HIV Care: Postexposure Prophylaxis

In this episode, Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVS, explores the data and recommendations for HIV postexposure prophylaxis (PEP).Listen as she gives perspectives on:The CDC algorithm for evaluation and treatment of potential HIV exposuresThe CDC guideline preferred and alternative PEP antiretroviral therapy regimensData for the use of the single-tablet regimen bictegravir/emtricitabine/tenofovir alafenamide for PEPRecommended laboratory monitoring with PEPThe initiation of pre-exposure prophylaxis following a course of PEP, when appropriatePresenter:Michelle D. Collins-Ogle, MD, FAAP, FPIDS, AAHIVSAssistant Professor of PediatricsDivision of Pediatric Infectious DiseasesPediatric and Adolescent HIV Children’s Hospital at MontefiorePediatric Hospital of Albert Einstein College of MedicineBronx, New York Follow along with the slides at:https://bit.ly/3NBVXWNSee the entire program at:https://bit.ly/3fOl0XX Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

There are no comments yet.

Please log in to write the first comment.